Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Lusutrombopag

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 4VANCOCIN ITALIA

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    VANCOCIN ITALIA

    LUSUTROMBOPAG

    arrow
    BioAsia
    Not Confirmed

    VANCOCIN ITALIA

    Country
    arrow
    BioAsia
    Not Confirmed

    Patent Expiration Date : 2024-09-05

    LUSUTROMBOPAG

    US Patent Number : 7601746

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 210923

    Patent Use Code : U-2344

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2024-09-05

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    VANCOCIN ITALIA

    LUSUTROMBOPAG

    arrow
    BioAsia
    Not Confirmed

    VANCOCIN ITALIA

    Country
    arrow
    BioAsia
    Not Confirmed

    Patent Expiration Date : 2031-09-29

    LUSUTROMBOPAG

    US Patent Number : 9427402

    Drug Substance Claim :

    Drug Product Claim : Y

    Application Number : 210923

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2031-09-29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    VANCOCIN ITALIA

    LUSUTROMBOPAG

    arrow
    BioAsia
    Not Confirmed

    VANCOCIN ITALIA

    Country
    arrow
    BioAsia
    Not Confirmed

    Patent Expiration Date : 2028-07-29

    LUSUTROMBOPAG

    US Patent Number : 8889722

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 210923

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2028-07-29

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    VANCOCIN ITALIA

    LUSUTROMBOPAG

    arrow
    BioAsia
    Not Confirmed

    VANCOCIN ITALIA

    Country
    arrow
    BioAsia
    Not Confirmed

    Patent Expiration Date : 2030-01-21

    LUSUTROMBOPAG

    US Patent Number : 8530668

    Drug Substance Claim : Y

    Drug Product Claim : Y

    Application Number : 210923

    Patent Use Code :

    Delist Requested :

    Patent Use Description :

    Patent Expiration Date : 2030-01-21

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF